Danish Stock News

Key Insights The projected fair value for Demant is kr.437 based on 2 Stage Free Cash Flow to Equity Demant's kr.230...

Recent market commentary has identified Coloplast as trading below its estimated fair value, highlighting anticipated earnings growth and operational progress as appealing factors for investors. This perception of undervaluation has attracted heightened attention as investors seek quality opportunities in the healthcare sector, especially during a period of optimistic European market sentiment. We'll explore how perceptions of Coloplast's undervaluation could impact its investment case and...

cBrain A/S' ( CPH:CBRAIN ) price-to-earnings (or "P/E") ratio of 68.6x might make it look like a strong sell right now...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

While Rockwool A/S ( CPH:ROCK B ) might not have the largest market cap around , it received a lot of attention from a...

Trying to decide what to do with Novo Nordisk stock right now? You are not alone. For investors, few names stir up as much debate and optimism as Novo Nordisk. After a turbulent year where the stock fell by over 50% from its highs, recent weeks have brought a sense of momentum back into the picture. Novo Nordisk shares have rallied 10% over just the past week, and are up a similar 10.4% over the last month, showing that the market may be reassessing its outlook and appetite for the...

This week we saw the Netcompany Group A/S ( CPH:NETC ) share price climb by 18%. But that can't change the reality that...

As European markets reach record highs, buoyed by a rally in technology stocks and expectations for lower U.S. borrowing costs, investors are keenly observing growth companies with substantial insider ownership. In such an environment, companies where insiders hold significant stakes can be particularly appealing as they often signal confidence in the company's future prospects and alignment of interests with shareholders.

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...

It's not a stretch to say that AGF A/S' ( CPH:AGF B ) price-to-sales (or "P/S") ratio of 2.1x seems quite...

Danske Bank (CPSE:DANSKE) shares have edged higher in recent sessions, catching the attention of investors looking for clues in the bank's performance. The subtle upward move prompts a closer look at what is driving sentiment. See our latest analysis for Danske Bank. While the past week saw only minor shifts in Danske Bank's share price, what stands out is its ongoing momentum over the year, with a notable year-to-date share price return of 32.8%. Even when considering fluctuations, Danske...

Vestas Wind Systems (CPSE:VWS) has caught extra attention after revealing significant new wind turbine orders across Germany, Denmark, the UK, Italy, and the USA. This highlights ongoing demand for its advanced technology and services. See our latest analysis for Vestas Wind Systems. Recent waves of wind project wins have put Vestas Wind Systems back in the spotlight, but the stock’s longer-term story is more measured. Even as new orders roll in and the momentum for clean energy builds...

Earlier this month, A.P. Møller - Mærsk announced a renewed strategic focus on operational reliability and higher shipping volumes through the Gemini Cooperation, while highlighting its strong net cash position that supports ongoing share repurchase plans. This combination of financial strength and a shift in industry focus sets Maersk apart in a sector currently facing freight rate declines and oversupply challenges. We'll now explore how Maersk’s balance sheet resilience could influence...

Jyske Bank (CPSE:JYSK) has been trending higher over the past month, and investors are assessing whether the stock’s recent performance aligns with the bank’s underlying fundamentals. As the Danish financial sector evolves, Jyske Bank’s track record invites a closer look. See our latest analysis for Jyske Bank. Jyske Bank’s share price has shown a steady upward trend this year, reflecting improving investor sentiment. With a 2024 year-to-date share price return of 38.3% and a 1-year total...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

If you’re wondering what to do with Ørsted stock right now, you’re not alone. Investors everywhere are sizing up their options after a rough ride this year. While shares rebounded 4.8% over the past week, the broader trend still looks challenging, with the price down a staggering 41.0% in the last month. Year-to-date, the stock has been battered, down 64.1%. If you zoom out even further, the five-year loss stands at a stunning 77.2%. Behind these moves is shifting sentiment about both the...

It looks like ChemoMetec A/S ( CPH:CHEMM ) is about to go ex-dividend in the next four days. The ex-dividend date...

A.P. Møller Mærsk (CPSE:MAERSK B) shares have been relatively steady lately, picking up around 1% in the past day after drifting slightly lower this month. Investors are watching for signals on demand and shipping rates. See our latest analysis for A.P. Møller - Mærsk. While shares have seen minor shifts in recent weeks, the bigger picture shows that A.P. Møller - Mærsk’s share price has been steady overall. Long-term total shareholder returns have outpaced recent price moves, suggesting...

Vestas Wind Systems announced a series of significant wind turbine orders in the past week, including over 239 MW across eight projects in Germany, additional capacity in Italy and the USA, and projects across Europe, the Americas, and Asia as part of its third quarter 2025 order intake. These project wins highlight Vestas’ ability to secure large-scale orders with tailored turbine solutions and long-term service agreements, reinforcing its global presence in diverse markets. We’ll now...

Genmab (CPSE:GMAB) shares have captured investor attention recently as the stock delivered a 4% gain over the past week, building on impressive momentum. With strong year-to-date and recent month returns, this Danish biotech remains in focus. See our latest analysis for Genmab. Genmab continues to draw investor interest as its recent share price momentum extends a streak of steady gains, suggesting renewed optimism around its growth prospects. The stock’s impressive year-to-date share price...

Novo Nordisk (CPSE:NOVO B) shares have drifted slightly higher over the past week amid a relatively quiet period for the company. Investors continue watching for any signs of momentum as they assess recent performance trends. See our latest analysis for Novo Nordisk. Novo Nordisk’s share price has barely budged over the past month, but that quiet spell comes after a remarkable multi-year run. The company’s 5-year total shareholder return of almost 82% highlights how long-term momentum has...

Tryg (CPSE:TRYG) shares have been relatively steady lately, with the stock showing modest movement over the past week and month. Investors may be taking a closer look at performance and valuation trends as they consider their next moves. See our latest analysis for Tryg. Tryg’s share price momentum has been generally positive in 2024, which has helped to offset quieter stretches seen in recent months. Over the longer haul, total shareholder returns stand at over 31% for five years, reflecting...

Key Insights The projected fair value for FLSmidth is kr.657 based on 2 Stage Free Cash Flow to Equity FLSmidth is...